Thyroid cancer trials in South Korea
6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Seoul
- Age
- 18 years to 100 years
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Hwasun, Pusan, Seoul, Suwon
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00 - Phase 2Not yet taking people in South KoreaSacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
- Where
- Gyeonggi-do, Seoul
- Age
- 18 years to 99 years
- People
- 68 worldwide
- Run by
- National Cancer Centre, Singapore
See details and how to joinNCT07521670 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Cheongju-si, Hwasun-eup, Hwasun-gun, Seoul
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleAn Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T)
- Where
- Gyeonggi-do, Seoul
- Age
- 19 years and over
- People
- 500
- Run by
- Ilsan Cha hospital
See details and how to joinNCT06158360 - No phaseEnrolling by invitationActive Surveillance for Low-risk Papillary Thyroid Carcinoma
- Where
- Goyang-si, Seongnam, Seoul
- Age
- 18 years and over
- People
- 499
- Run by
- National Cancer Center, Korea
See details and how to joinNCT06261190